Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-05-04
2009-08-04
Jiang, Dong (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S351000
Reexamination Certificate
active
07569667
ABSTRACT:
The invention relates to soluble proteins which bind to the molecule known as IL-TIF/IL-22. The proteins can antagonize the effect of IL-TIF/IL-22 on target cells. The nucleic acid molecules encoding the proteins, and uses of the protein, are also described.
REFERENCES:
patent: 6740520 (2004-05-01), Goddard et al.
patent: 6897292 (2005-05-01), Presnell et al.
patent: 7094570 (2006-08-01), Renauld et al.
patent: 2001/0023070 (2001-09-01), Ebner et al.
patent: 2002/0012669 (2002-01-01), Presnell et al.
patent: 2003/0022827 (2003-01-01), Weiss et al.
patent: 1191035 (2001-08-01), None
patent: WO 94/01548 (1994-01-01), None
patent: WO 98/02542 (1998-01-01), None
patent: WO 99/07848 (1999-02-01), None
patent: WO 99/61617 (1999-12-01), None
patent: WO 00/24758 (2000-05-01), None
patent: WO 00/55204 (2000-09-01), None
patent: WO 00/65027 (2000-11-01), None
patent: WO 00/73457 (2000-12-01), None
patent: WO 01/36467 (2001-05-01), None
patent: WO 01/40467 (2001-06-01), None
patent: WO 01/46422 (2001-06-01), None
patent: WO 01/66740 (2001-09-01), None
patent: WO 01/98432 (2001-12-01), None
patent: WO 02/12345 (2002-02-01), None
patent: WO 02/24888 (2002-03-01), None
patent: WO 02/066647 (2002-08-01), None
patent: WO 02/077174 (2002-10-01), None
Sequence search results: sequence alignment between 1) SEQ ID No. 11 of the present application and SEQ ID No. 2 of US6,740,520; 2) sequence alignment between SEQ ID No. 11 of the present application and SEQ ID No. 11 of 09/919,162.
Phillimore B., Locus HSJ503F13 standard, genomic DNA; HUM: 113811 BP; Accession No. AL050337, May 26, 1999.
Parrish-Novak, et al., “Interleukin-21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function,” Nature, 408:57-63, Nov. 2, 2000.
Xie, et al., “Interleukin (IL-22), a Novel Human Cytokine That Signals Through the Interleukin Receptor-related proteins CRF 2-4 and IL-22R,” J. Biol. Chem., 275(40):51335-51339, Oct. 6, 2000.
Dumoutier, et al., “Cloning and Characterization of IL-22 Binding Protein, a Natural Antagonist of IL-10 Related T Cell-Derived Inducible Factor/IL-22,” J. Immunol., 166:7090-7095, 2001.
Gruenberg, et al., “A soluble homologue of the human IL-10 receptor with preferential expression in placenta,” Genes & Immunity, 2:329-334, 2001.
Kotenko, et al., “Identification of the Functional interleukin-22 (IL-22) Receptor Complex,” J. Biol. Chem., 276(4):2725-2732, 2001.
Kotenko, et al., “Identification, Cloning and Characterization of a Novel Soluble Receptor That Binds IL-22 and Neutralizes Its Activity,” J. Immunol., 166:7096-7103, 2001.
Xu, et al., “A soluble Class II Cytokine Receptor, IL-22 RA2, is a Naturally Occurring IL-22 antagonist,” Proc. Natl. Acad. Sci. USA, 98(17):9511-9516, 2001.
Xie, et al., “Interleukin (IL)-22, A Novel Human Cytokine That Signals Through The Interferon Receptor-related proteins CRF2-4 and IL-22R,” J. Biol. Chem., 275(40):31335-31339, 2000.
Opal, et al., “Impact of Basic Research on Tomorrow's Medicine,” Chest, 117:1162-1172, 2000.
Kotenko, et al., “Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes,” Oncogene, 19:2557-2565, 2000.
Dumoutier, et al., “Human interleukin-10 related T cell derived inducible factor: Molecular Cloning and Functional Characterization As An Hepatocyte Stimulating Factor,” Proc. Natl. Acad. Sci. USA, 97(18):10144-10149, 2000.
Fernandez-Botran, “Soluble Cytokine Receptors: Basic Immunology and Clinical Applications,” Critical Reviews in Clinical Laboratory Sciences, 36(3):165-224, 1999.
Kotenko, et al., “Identification and Functional Characterization of a Second Chain of the Interleukin-10 Receptor Complex,” EMBOJ, 16(19):5894-5903, 1997.
Meagher, et al., “Assay For Measuring Soluble Cellular Adhesion Molecules and Soluble Cytokine Receptors,” J. Immunol. Meth., 191:97-112, 1996.
Heaney, et al., “Soluble Cytokine Receptors,” Blood, 87(3):847-857, 1996.
Dumoutier Laura
Renauld Jean-Christophe
Jiang Dong
Latimer, Mayberry & Matthews IP Law, LLP
Wyeth
LandOfFree
Isolated soluble IL-TIF/IL-22 receptor or binding protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated soluble IL-TIF/IL-22 receptor or binding protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated soluble IL-TIF/IL-22 receptor or binding protein... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4058821